T2 Biosystems Expands International Market Presence with Sale of Four T2Dx® Instruments to European Distributor
T2 Biosystems sold four T2Dx® Instruments to expand its international presence in sepsis-testing technology.Quiver AI SummaryT2 Biosystems, Inc. announced the sale of four T2Dx® Instruments to its European...
T2 Biosystems Extends Supplier Agreement with Vizient Through March 2026 for Rapid Sepsis Detection Products
T2 Biosystems extends its agreement with Vizient, enhancing hospital access to rapid sepsis diagnostics through 2026.Quiver AI SummaryT2 Biosystems, Inc. has announced the extension of its supplier agreement...
T2 Biosystems Announces Licensing Plans to Enhance Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
T2 Biosystems announced plans to license its technology for direct-from-whole-blood detection of sepsis-causing pathogens, aiming to expand market access.Quiver AI SummaryT2 Biosystems, Inc. has announced...